A recent study in animals found that severe pneumonia, which can contribute to death from influenza, can be stopped with a drug derived from a natural human protein.
The scientists conducted experiments on mice, where they found that all untreated animals that were given a lethal dose of flu They died within days, while all of the infected mice treated with the experimental treatment survived and kept active and at weight – despite high levels of influenza virus in their lungs.
According to a site report ” sciencedaily“The experimental treatment is a big dose of MG53 , Which is part of the family of proteins that play an essential role in cell membrane repair MG53 Already as a potential treatment for conditions ranging from Alzheimer’s disease to persistent skin wounds, it works to prevent death from a deadly influenza infection by preventing excessive inflammation – without having any effect on the virus itself.
Natural protein prevents lung damage due to influenza–
Researchers are currently testing the effects of the treatment in mice infected with the virus -CoV-2 , Which is the Corona virus that causes COVID-19.
“I’ve never seen anything like this before,” said Jacob Yunt, associate professor of microbial infection and immunology at Ohio State University and co-author of the study. “Although these mice carried the same viral load as the untreated mice, they did not get very sick – with the lethal dose of influenza.”
Damage to lung tissue from infections is deadly because it allows fluid and cells to accumulate in the airways, preventing the lungs from absorbing oxygen.
– .
